Orexo: Zubsolv Rx data – November
Research Update
2017-12-08
10:12
The market share for Zubsolv in November (four weeks rolling average) was at 4.97% (prescriptions) and 5.19% (quantity). This was pretty much unchanged compared to the market share in October. The underlying market grew y/y by 8.2% (prescriptions) and of 9.3% (quantity).
KP
Klas Palin
Disclosures and disclaimers